# Physician Decision Log 02

Date: 2026-05-31

Purpose: durable record that Clinical Story Skeleton v1 is locked after physician review and Codex audit.

Status: Clinical Story Skeleton v1 RATIFIED.

Review artifact: `worlds/korvin-merrow/world-spec-prep/reviews/clinical-story-skeleton-review.md`

Overall recommendation: GO to Identity Package and Governance Package preparation. World Spec drafting remains blocked until Alexander explicitly authorizes drafting.

Ratification artifact: `worlds/korvin-merrow/world-spec-prep/ratifications/clinical-story-skeleton-ratification.md`

Identity Package v1 artifact: `worlds/korvin-merrow/world-spec-prep/locked/identity-package-v1.md`

Identity Package review addendum: `worlds/korvin-merrow/world-spec-prep/reviews/identity-package-review-addendum.md`

Governance Package v1 candidate: `worlds/korvin-merrow/world-spec-prep/locked/governance-package-v1.md`

Governance Package clarification: `worlds/korvin-merrow/world-spec-prep/reviews/governance-package-clarification.md`

Governance Package ratification: `worlds/korvin-merrow/world-spec-prep/ratifications/governance-package-ratification.md`

Key Milestones Calendar Skeleton v1: `worlds/korvin-merrow/world-spec-prep/locked/key-milestones-calendar-skeleton-v1.md`

Key Milestones Calendar ratification: `worlds/korvin-merrow/world-spec-prep/ratifications/key-milestones-calendar-ratification.md`

Baseline Anchor Package v1: `worlds/korvin-merrow/world-spec-prep/locked/baseline-anchor-package-v1.md`

Baseline Anchor Package ratification: `worlds/korvin-merrow/world-spec-prep/ratifications/baseline-anchor-ratification.md`

Clinical Story Timeline Package v1: `worlds/korvin-merrow/world-spec-prep/locked/clinical-story-timeline-package-v1.md`

Clinical Story Timeline Package ratification: `worlds/korvin-merrow/world-spec-prep/ratifications/clinical-story-timeline-ratification.md`

Task Architecture Package v1: `worlds/korvin-merrow/world-spec-prep/locked/task-architecture-package-v1.md`

Task Architecture Package ratification: `worlds/korvin-merrow/world-spec-prep/ratifications/task-architecture-ratification.md`

## Locked Clinical Story Skeleton v1

Patient:

- Korvin Merrow.
- 62-year-old male.
- World Type: Typical Clinical World.

Baseline:

- Lives with family.
- Independent but slowed by chronic illness.
- Occasional cane use.
- Mild age-related forgetfulness only.
- Chronic diseases generally stable before current decline.

PMR / Prednisone History:

- Several-year PMR history.
- Chronic prednisone exposure.
- Multiple prior flares and taper attempts.
- Recent taper initiated because symptoms appeared controlled.
- Prednisone history contains reconstructable source-of-truth inconsistencies across documentation, medication history, family understanding, and patient recollection.

Three-Week Decline:

- Reduced stamina.
- Reduced activity.
- Poor appetite.
- Reduced fluid intake.
- Increasing weakness.
- Increasing family dependence.
- Possible urinary symptoms.
- Progressive unsteadiness.
- Progressive cognitive slowing.

Escalation:

- Medication-management mistakes.
- Increased dependence.
- Lightheadedness.
- Near-fall event.
- Family recognizes meaningful deviation from baseline and seeks care.

ED Presentation:

- Suspected urinary-source infection.
- Dehydration.
- AKI risk.
- Altered baseline mental status.
- Functional decline.
- Sepsis-oriented management is clinically reasonable.
- Infection is a contributor, not the entire explanation.

Hospital Course:

- HD1: admission and stabilization.
- HD2: partial improvement and consultant involvement begins.
- HD3: PT/OT identify functional concerns.
- HD4: consultant tensions emerge and steroid-history inconsistencies are recognized.
- HD5: medical improvement continues and disposition questions become dominant.
- HD6: patient appears medically improved but discharge remains debatable.

Discharge State:

- Infection improved.
- AKI improving.
- Hemodynamics stable.
- Mental status improved.
- Oral intake improved.

Unresolved:

- Functional reserve uncertain.
- Medication restart strategy not fully settled.
- Steroid interpretation imperfect.
- Family concern persists.
- Disposition risk remains meaningful.

Core theme:

- Medically improving.
- Operationally dangerous.

Primary failure target:

- Disposition safety.
- Functional decline recognition.
- Discharge-readiness reasoning.

Near-fall framework:

- Multi-factorial.
- Not attributable to a single cause.
- Contributors include poor intake, volume depletion, medication effects, neuropathy, deconditioning, infection physiology, and steroid-related physiology.

## Carry-Forward Requirements

- Do not convert this skeleton into final World Spec prose until Alexander explicitly authorizes World Spec drafting.
- Do not create a file inventory from this skeleton yet.
- Use the skeleton to support Identity Package and Governance Package decisions.
- Preserve steroid physiology as important but not dominant.
- Preserve infection as real/reasonable initially but not the entire explanation.
- Preserve discharge safety as the primary failure target.

## Ratified Governance Guardrails

### Friction Correction

Locked wording: Endocrinology vs Primary Team.

Do not use: Endocrinology vs Documentation.

Rationale:

- Documentation is evidence.
- Documentation is not a friction participant.
- The steroid-record discrepancy remains a trap.
- The friction remains a human-to-human disagreement about steroid risk interpretation and management.

### Prednisone Source-of-Truth Hierarchy

Locked hierarchy:

1. Rheumatology attending recommendation.
2. Verified medication reconciliation.
3. Pharmacy / refill history.
4. Family report.
5. Patient recollection.

Purpose:

- Resolve source-of-truth ambiguity before World Spec construction.
- Establish authority ordering for steroid timeline interpretation.
- Keep the prednisone discrepancy as a reconstructable trap rather than an arbitrary contradiction.

### Family vs Team Friction Balance

Both positions are defensible.

Family position:

- Not back to baseline.
- Functional concerns remain.
- Safety concerns remain.

Primary team position:

- Infection improved.
- AKI improving.
- Mental status improved.
- Oral intake improving.
- Follow-up available.
- Discharge is clinically defensible.

Purpose:

- Prevent the friction from collapsing into a one-sided disposition decision.
- Preserve realistic discharge-readiness judgment.

### Near-Fall Guardrail

The near-fall event is intentionally multi-factorial.

No single contributor is intended to explain the event.

Potential contributors include:

- Poor intake.
- Volume depletion.
- Medication effects.
- Neuropathy.
- Deconditioning.
- Infection physiology.
- Steroid-related physiology.

Purpose:

- Preserve the disposition-safety world design.
- Prevent reveal-drift toward a single-cause explanation.

## Locked Identity Package v1

Status: LOCKED.

| Field | Locked value |
| --- | --- |
| Name | Korvin Merrow |
| DOB | 1964-02-18 |
| Age | 62 |
| MRN | KM-6427819 |
| Height | 178 cm (5'10") |
| Weight | 97 kg (214 lb) |
| BMI | 30.6 |
| Allergy | Lisinopril (cough) |
| Code Status | Full Code |

Consistency checks:

- Age is consistent with DOB for a 2026 encounter after 2026-02-18.
- BMI is consistent with 97 kg and 178 cm.
- Identity details do not conflict with the approved Brainstorm.
- Identity details do not conflict with the ratified Clinical Story Skeleton.
- Later calendar skeleton must preserve age-62 consistency unless Alexander explicitly reopens DOB or age.

Carry-forward implementation notes:

- Lisinopril cough should be treated as an ACE-inhibitor intolerance during World Spec construction.
- ARNI therapy should eventually have a coherent prior ACE-inhibitor transition history.
- Baseline function, baseline creatinine, dry weight, and similar baseline anchors should be explicitly placed during Patient Profile / Clinical History design.
- These notes do not reopen Identity Package v1 and do not authorize Governance Package work or World Spec drafting.

## Governance Package v1 Candidate

Status: RATIFIED.

Care team roster:

- Primary Team: Hospitalist Service.
- Consultants: Cardiology, Nephrology, Endocrinology.
- Functional Team: Physical Therapy, Occupational Therapy.
- Transition Team: Case Management, Social Work.
- Stakeholders: Patient, Family/Caregiver, Primary Care Physician.

Authority hierarchy:

1. Attending Hospitalist.
2. Consulting Attending Specialists.
3. PT/OT Functional Assessments.
4. Case Management / Social Work.
5. Family Reports.
6. Patient Recollection.

Master source-of-truth hierarchy for clinical facts:

1. Attending Documentation.
2. Verified Medication Reconciliation.
3. Pharmacy History.
4. Consultant Documentation.
5. Primary Care Documentation.
6. Family Report.
7. Patient Recollection.

Preserve the previously ratified prednisone hierarchy:

1. Rheumatology attending recommendation.
2. Verified medication reconciliation.
3. Pharmacy / refill history.
4. Family report.
5. Patient recollection.

Confirmed conditions:

- HFrEF.
- CKD Stage 3.
- Type 2 Diabetes.
- CAD.
- Hypertension.
- Hyperlipidemia.
- OSA.
- Diabetic Neuropathy.
- PMR.
- Anemia of CKD.
- Osteoporosis/Osteopenia.

Presumed / active questions:

- Current infection source.
- Steroid contribution.
- Adrenal suppression contribution.
- Degree of dehydration.
- Relative medication contribution.
- Discharge readiness.

Final friction table:

- Cardiology vs Nephrology: medication restart timing.
- Family vs Primary Team: discharge readiness.
- Endocrinology vs Primary Team: steroid interpretation and risk.

Administrative deliverable decision: YES. At least one future task should involve transition of care, discharge planning, care coordination, or follow-up planning.

Workflow consolidation: use Acute Hospital Management as the single workflow umbrella, with subdomains of diagnosis, medication management, consultant synthesis, functional assessment, and disposition planning. Final task workflow lines must still use exact approved tracker names.

Clarifications accepted before ratification review:

- Authority hierarchy and source-of-truth hierarchy are distinct.
- Authority Hierarchy is used for role-based governance, disposition interpretation, functional/discharge evidence, stakeholder input, and decision ownership.
- Source-of-Truth Hierarchy is used for factual conflict resolution, especially medication history, outpatient records, consultant documentation, family reports, and patient recollection.
- If both appear relevant, the World Spec must state which hierarchy governs the task or trap.
- Authority hierarchy resolves factual/documentation conflicts; it does not resolve clinical recommendation disagreements.
- Consultant disagreements must be reconciled through evidence synthesis, timing, trends, patient status, and discharge safety, not by automatically deferring to the highest-ranked authority.
- Confirmed steroid-related osteoporosis/osteopenia reflects cumulative chronic steroid exposure but does not prove current symptoms are primarily caused by adrenal suppression.
- Current adrenal/steroid contribution remains an active interpretive question.
- AutoQC 2.107 workflow count and 2.108 administrative deliverable remain task-architecture watch items and are not resolved inside Governance Package v1.

Ratification:

- Claude closeout review determination: would ratify today, YES.
- Claude final recommendation: GO.
- Governance Package v1 Status: RATIFIED.
- Physician Architecture Layer Status: COMPLETE.

Completed Architecture Layers:

- Brainstorm: APPROVED.
- Temporal Architecture: LOCKED.
- Clinical Story Skeleton: RATIFIED.
- Identity Package: LOCKED.
- Governance Package: RATIFIED.

Active future watch items:

- AutoQC 2.107 workflow-count resolution.
- AutoQC 2.108 administrative-deliverable resolution.

These are task-architecture concerns, not governance defects.

## Key Milestones Calendar Skeleton v1

Status: LOCKED.

Purpose: canonical date framework for World Spec construction preparation.

Calendar anchors:

- Approximate decline begins: 04/27/2026.
- Final pre-admission week begins: 05/11/2026.
- Day before presentation: 05/17/2026.
- Admission / HD1: 05/18/2026.
- HD2: 05/19/2026.
- HD3: 05/20/2026.
- HD4: 05/21/2026.
- HD5: 05/22/2026.
- HD6: 05/23/2026.
- World snapshot / world close: 05/23/2026 18:00.
- Discharge anchor: 05/24/2026.
- +7 day anchor: 05/31/2026.
- +30 day anchor: 06/23/2026.

Locked doctrine:

- +7 and +30 anchors are measured from discharge anchor 05/24/2026.
- They are not measured from HD6 world close.

Boundary:

- This is a date framework only.
- It does not create final World Spec prose, task architecture, final file inventory, prompts, golden responses, grader guidance, or synthetic files.

## Baseline Anchor Package v1

Status: LOCKED.

Purpose: define baseline comparator values and baseline function anchors for later World Spec construction after physician review.

Locked anchors:

- Baseline creatinine.
- Baseline eGFR.
- Baseline hemoglobin.
- Baseline A1c.
- Dry weight approximately 97 kg.
- Baseline mobility.
- Baseline cognition.
- Baseline medication-management ability.
- Baseline home support.

Baseline functional status remains part of the approved baseline framework through mobility, cognition, medication-management ability, and home support.

Physician sign-off:

- Completed.
- Dry weight approximately 97 kg: APPROVED.
- Baseline anchor framework: APPROVED.

Claude ratification review:

- True defects: NONE.
- Blockers: NONE.
- Would lock today: YES.
- Final recommendation: GO.

Carry-forward note:

- Baseline blood pressure may be considered as a future candidate anchor during construction.
- Do not create a numeric baseline blood pressure value at this stage.

Boundary:

- These are baseline anchors, not admission labs or hospital-course trends.
- This does not create file inventory, task architecture, World Spec prose, prompts, golden responses, grader guidance, templates, reference files, or synthetic files.

## Clinical Story Timeline Package v1

Status: LOCKED.

Purpose: canonical story-evolution framework from pre-admission decline through HD1-HD6, discharge, +7, and +30 anchors.

Ratification:

- Cascade MCP Claude Review: Would lock today, YES. Status: LOCK READY. Final Recommendation: GO. True defects: none. Blockers: none.
- Claude Code Review: Would lock today, YES. Status: LOCK READY. Final Recommendation: GO. True defects: none. Blockers: none.

Completed construction-preparation chain:

- Key Milestones Calendar Skeleton: LOCKED.
- Baseline Anchor Package: LOCKED.
- Clinical Story Timeline Package: LOCKED.

Carry-forward file-construction note:

- Trap #3 is buried functional/cognitive evidence; the issue is that important evidence exists but is easy to miss.
- Trap #5 is a reassuring but incomplete discharge/source-hierarchy artifact; the issue is that a visible artifact appears sufficient if trusted alone.
- This distinction is a future file-construction concern, not a timeline defect.

Active future watch items:

- Medication Expansion Package v1 is now locked; future watch item is medication reconciliation construction, not baseline medication expansion.
- Comorbidity expansion to 12-15 conditions.
- Named-provider roster.
- Surgical-history documentation.
- AutoQC 2.107 workflow consolidation.
- AutoQC 2.108 administrative deliverable.
- Trap #3 vs Trap #5 concrete distinction during file construction.

Boundary:

- This does not authorize World Spec drafting, labs, vitals, medication schedules, file inventory, task architecture, prompts, golden responses, grader guidance, templates, reference files, or synthetic documents.

## Task Architecture Package v1

Status: LOCKED.

Purpose: formal task-architecture framework defining six task concepts across four exact approved catalog workflows before task drafting.

Locked workflows:

1. Discharge Medication Reconciliation.
2. Hospital Discharge Summary Generation.
3. Discharge Planning Documentation.
4. Interdisciplinary Care Plan Development and Documentation.

Physician decisions:

- Target task count: 6.
- Target workflow count: 4.
- Administrative deliverable: Discharge Planning Documentation / Care Coordination.
- TCM and readmission-risk reasoning remain embedded inside Discharge Planning Documentation rather than becoming standalone workflow categories.
- Consultant synthesis remains distinct.
- Coding, billing, and prior authorization are not preferred unless later required by source material.

Completed construction-preparation chain:

- Key Milestones Calendar Skeleton: LOCKED.
- Baseline Anchor Package: LOCKED.
- Clinical Story Timeline Package: LOCKED.
- Task Architecture Package: LOCKED.

Carry-forward watch items:

- AutoQC 2.108 administrative-deliverable reviewer-risk contingency.
- Differentiate three Discharge Planning Documentation task concepts later.
- Medication Expansion Package v1 is now locked; future watch item is medication reconciliation construction, not baseline medication expansion.
- Comorbidity expansion to 12-15 conditions.
- Named-provider roster.
- Surgical-history documentation.
- Trap #3 vs Trap #5 concrete file distinction.
- Exact task prompt / expected output / failure design still not created.

Boundary:

- This does not authorize task prompts, expected outputs, golden responses, grader guidance, file inventory, World Spec drafting, templates, reference files, or synthetic documents.

## Medication Expansion Package v1

Status: LOCKED.

Purpose: baseline medication architecture for Korvin Merrow before admission medication lists, hospital-course medication changes, discharge medication lists, medication reconciliation outputs, file inventory, tasks, or World Spec drafting.

Ratification:

- Independent Review #1: LOCK READY / YES / GO.
- Independent Review #2: LOCK READY / YES / GO.
- No true defects identified.
- No blockers identified.

Accepted physician decisions:

- Insulin lispro removed from baseline architecture.
- Insulin lispro reserved for future inpatient-only candidate use.
- Baseline medication count finalized at 20.
- Nitroglycerin retained.
- Polyethylene glycol retained.
- Senna retained.
- Cholecalciferol retained.

Preserved architecture:

- All other baseline medications preserved.
- All medication categories preserved.
- All trap architecture preserved.
- All friction architecture preserved.
- Baseline diabetes architecture remains aligned with locked baseline rationale: metformin plus basal insulin.
- Future inpatient glycemic-management reasoning remains available for discharge and medication-reconciliation construction.

Carry-forward watch items:

- Future inpatient glycemic-management reasoning.
- Future medication reconciliation construction.
- Comorbidity Expansion Package v1 is now locked; future watch item is condition-to-file consistency during later file construction, not baseline condition expansion.
- AutoQC 2.107 workflow-count discipline.
- AutoQC 2.108 administrative-deliverable reviewer-risk contingency.

Boundary:

- This does not authorize medication doses, medication schedules, medication timelines, admission medication lists, discharge medication lists, medication reconciliation outputs, tasks, prompts, expected outputs, golden responses, grader guidance, file inventory, World Spec drafting, templates, reference files, or synthetic documents.

## Comorbidity Expansion Package v1

Status: LOCKED.

Purpose: baseline chronic-condition architecture for Korvin Merrow before labs, vitals, hospital-course events, provider names, surgical history, file inventory, tasks, or World Spec drafting.

Ratification:

- Claude Code independent review: LOCK READY / YES / GO.
- Cascade/Windsurf Claude independent review: LOCK READY / YES / GO.
- Physician review: GO.
- No blockers.
- No clinical defects.
- No new dominant disease arc.
- No open clinical question answered.

Accepted physician decisions:

- Keep Class I obesity by locked BMI 30.6.
- Keep chronic GERD / acid-suppression indication.
- Keep chronic constipation tendency.
- Final baseline comorbidity count finalized at 14.

Clarification:

- Medication Expansion Package v1 remains locked at 20 baseline medications.
- Insulin lispro remains removed from baseline architecture and reserved for future inpatient-only logic.
- Comorbidity Expansion Package v1 correctly references the 20-medication baseline architecture.

Preserved architecture:

- Mixed physiology preserved.
- Trap architecture preserved.
- Friction architecture preserved.
- Medication architecture preserved.
- No active clinical question is resolved by the comorbidity expansion.

Carry-forward watch items:

- Named-provider roster package.
- Surgical-history package.
- Daily hospital-course framework.
- Future medication reconciliation construction.
- File inventory architecture.
- AutoQC 2.107 workflow-count discipline.
- AutoQC 2.108 administrative-deliverable contingency.
- Trap #3 vs Trap #5 concrete file distinction.

Boundary:

- This does not authorize labs, vitals, medication doses, medication schedules, hospital-course events, provider names, surgical history, tasks, prompts, expected outputs, golden responses, grader guidance, file inventory, World Spec drafting, templates, reference files, or synthetic documents.

## Provider Roster Package v1

Status: LOCKED.

Purpose: provider/care-team and stakeholder architecture for Korvin Merrow before World Spec construction, file planning, note authorship, synthetic documents, task prompts, expected outputs, golden responses, or grader guidance.

Ratification:

- Claude Review: YES / LOCK READY / GO.
- Claude Code Review: YES / LOCK READY / GO.
- No true defects identified.
- No blockers identified.
- No hierarchy conflicts identified.
- No friction collapse identified.
- No trap degradation identified.
- No governance incompatibilities identified.

Accepted physician decisions:

- Shared Merrow surname is intentional.
- Korvin Merrow and Mara Merrow may share the Merrow surname.
- Resident remains role-based.
- Pharmacy remains role-based.
- No additional provider naming is authorized.

Approved named high-authority roles:

- Attending hospitalist: Dr. Elian Vossmere.
- Cardiology attending: Dr. Maris Caldrane.
- Nephrology attending: Dr. Iven Solthar.
- Endocrinology attending: Dr. Nerea Veylorn.
- Primary care physician: Dr. Talia Quenor.
- Outpatient rheumatology attending: Dr. Soren Halvek.
- Family/caregiver stakeholder: Mara Merrow.

Approved role-based contributors:

- Hospitalist resident / covering clinician.
- Bedside nursing team.
- Physical Therapy.
- Occupational Therapy.
- Case Management.
- Social Work.
- Pharmacy / medication reconciliation pharmacist.

Compatibility confirmed:

- Authority hierarchy compatibility confirmed.
- Master source-of-truth compatibility confirmed.
- Prednisone hierarchy compatibility confirmed.
- Friction architecture preserved.
- Trap architecture preserved.
- Governance compatibility confirmed.

Carry-forward watch items:

- Named-provider roster must not expand without Alexander approval.
- Resident remains role-based unless future construction explicitly requires a named recurring covering clinician.
- Pharmacy remains role-based unless future medication-reconciliation construction explicitly requires a named recurring pharmacist.
- Surgical-history package.
- Daily hospital-course framework.
- Future medication reconciliation construction.
- File inventory architecture.
- Source-of-truth and document-provenance traceability.
- AutoQC 2.107 workflow-count discipline.
- AutoQC 2.108 administrative-deliverable contingency.
- Trap #3 vs Trap #5 concrete file distinction.

Boundary:

- This does not authorize clinical notes, provider-authored documents, file inventory, task prompts, expected outputs, golden responses, grader guidance, medication schedules, hospital-course events, labs, vitals, World Spec drafting, templates, reference files, or synthetic documents.

## Surgical History Package v1

Status: LOCKED.

Artifact: `worlds/korvin-merrow/world-spec-prep/locked/surgical-history-package-v1.md`

Ratification: `worlds/korvin-merrow/world-spec-prep/ratifications/surgical-history-ratification.md`

Purpose:

- Define pre-world surgical/procedural history architecture before Daily Hospital Course Framework, World Spec construction, file inventory planning, synthetic documents, task prompts, expected outputs, goldens, or grader guidance.

Confirmed surgical/procedural anchors:

- Remote percutaneous coronary intervention with coronary stent placement.
- Remote diagnostic sleep study confirming obstructive sleep apnea.

Excluded / noise-controlled procedures:

- ICD / CRT / pacemaker.
- Coronary artery bypass grafting.
- Dialysis access creation or kidney procedure.
- Major orthopedic fracture repair or joint replacement.
- Limb amputation or major diabetic foot surgery.
- Temporal artery biopsy or rheumatologic diagnostic procedure.
- Screening colonoscopy for v1 purposes.

Guardrails:

- Surgical/procedural history should remain background realism and provenance support.
- It should not create a new dominant disease arc.
- It should not answer open clinical questions.
- It should not collapse mixed physiology.
- It should not weaken Trap #1, Trap #2, Trap #3, or Trap #5.
- It should not create operative reports, procedure notes, hospital-course events, labs, vitals, file inventory, task prompts, expected outputs, goldens, grader guidance, synthetic files, World Spec prose, templates, or reference files.

Carry-forward watch items:

- Keep PCI remote so aspirin-only baseline remains consistent.
- Decide procedural provenance during file inventory.
- Daily Hospital Course Framework v1 is locked.
- File Inventory Architecture v1 is locked; final table construction remains deferred.
- World Spec construction is authorized, but downstream artifacts remain unstarted until specifically authorized.
- Trap #3 vs Trap #5 concrete file distinction remains deferred.
- AutoQC 2.107 workflow-count discipline remains preserved.
- AutoQC 2.108 administrative-deliverable contingency remains preserved.

## Daily Hospital Course Framework v1

Status: LOCKED.

Artifact: `worlds/korvin-merrow/world-spec-prep/locked/daily-hospital-course-framework-v1.md`

Ratification: `worlds/korvin-merrow/world-spec-prep/ratifications/daily-hospital-course-framework-ratification.md`

Purpose:

- Define canonical HD1-HD6 daily evolution before World Spec construction, file inventory architecture, synthetic file construction, task implementation, prompt construction, expected outputs, golden responses, or grader guidance.

Locked framework scope:

- HD1-HD6 primary clinical state.
- What changed since prior day.
- What improved.
- What remains concerning.
- Active frictions.
- Active traps.
- Relevant provider groups.
- Disposition readiness status.
- Improvement trajectory.
- Friction activation timeline.
- Trap activation timeline.
- Provider involvement timeline.
- Disposition-safety framework.

Guardrails:

- This is a major bridge artifact, not a small package.
- Preserve mixed physiology.
- Preserve no hidden single answer.
- Preserve no reveal-drift.
- Preserve improving but not safely solved.
- Preserve medically improving but operationally dangerous discharge logic.
- Preserve both sides of each friction as defensible.
- Preserve Trap #3 as buried functional/cognitive evidence and Trap #5 as visible but incomplete discharge/source-hierarchy artifact.

Boundary:

- This does not authorize labs, lab trends, vitals, medication doses, medication schedules, medication orders, clinical notes, consultant notes, discharge summaries, operative reports, procedure notes, file inventory, tasks, prompts, expected outputs, goldens, grader guidance, synthetic files, World Spec prose, templates, or reference files.

Ratification findings:

- Daily progression realism verified.
- Timeline consistency verified.
- Friction architecture verified.
- Trap architecture verified.
- Provider involvement timeline verified.
- Disposition-safety architecture verified.
- Future workflow compatibility verified.
- Preparation-layer completion verified.

Preparation Layer:

- Status: COMPLETE.

World Spec Construction:

- Status: AUTHORIZED.
- Final file inventory table rows, synthetic files, tasks, prompts, expected outputs, goldens, grader guidance, notes, labs, vitals, and hospital-course documentation have not started.

## World Spec Skeleton v1

Status: LOCKED.

Artifact: `worlds/korvin-merrow/world-spec-construction/locked/world-spec-skeleton-v1.md`

Ratification: `worlds/korvin-merrow/world-spec-construction/ratifications/world-spec-skeleton-ratification.md`

Review outcomes:

- Windsurf Claude Review: YES / LOCK READY / GO.
- Claude Code Review: YES / LOCK READY / GO.
- No true defects.
- No blockers.
- No orphaned locked packages.
- No template conflicts.
- No hierarchy conflicts.
- No timeline conflicts.
- No friction or trap collapse.
- No premature file inventory, task construction, prompt, golden, or grader creation.

Watch items:

- Future World File Plan construction must follow AutoQC v6.3 requirements, including the 8-column file-plan structure.
- Transcript packaging remains a future submission-layer activity.
- Administrative-deliverable watch item (AutoQC 2.108) remains preserved as a future-construction consideration.

World Spec Skeleton Phase:

- Status: COMPLETE.

World Spec Construction:

- Status: COMPLETE.

## World Spec v1

Status: LOCKED.

Artifact: `worlds/korvin-merrow/world-spec-construction/locked/world-spec-v1.md`

Ratification: `worlds/korvin-merrow/world-spec-construction/ratifications/world-spec-v1-ratification.md`

Review outcome:

- Windsurf Claude Review: YES / LOCK READY / GO.
- Claude Code Review: YES / LOCK READY / GO.
- No true defects identified.
- No blockers identified.
- Exact fidelity verified against all locked source packages.
- No timeline, hierarchy, medication, comorbidity, or provider drift.
- No friction collapse, trap collapse, reveal drift, or hidden-answer drift.
- Mixed physiology preserved.
- Task architecture support preserved.
- Studio alignment preserved.

Preserved future-construction watch items:

- Section 3 World File Plan must use AutoQC v6.3 8-column structure.
- Trap #3 vs Trap #5 distinction remains protected.
- Insulin lispro remains inpatient-only candidate logic.
- AutoQC 2.108 administrative deliverable watch item remains preserved.
- Transcript packaging remains future submission-layer activity.
- File Inventory Architecture v1 locked; File Inventory v1 Table Construction not yet started.
- Synthetic world files not yet started.
- Task Specifications not yet started.
- Task prompts not yet started.
- Expected outputs not yet started.
- Goldens not yet started.
- Grader guidance not yet started.
- AutoQC not yet started.
- DOCX population not yet started.
- Studio submission packaging not yet started.

## File Inventory Architecture v1

Status: LOCKED.

Artifact: `worlds/korvin-merrow/file-inventory/locked/file-inventory-architecture-v1.md`

Ratification: `worlds/korvin-merrow/file-inventory/ratifications/file-inventory-architecture-ratification.md`

Review outcome:

- Windsurf Claude Review: YES / LOCK READY / GO.
- Claude Code Review: YES / LOCK READY / GO.
- No true defects identified.
- No blockers identified.
- File ecosystem is faithful to locked World Spec v1.
- All four locked workflows have file support.
- All five traps have planned document substrates.
- Trap #3 vs Trap #5 distinction is preserved.
- All three frictions have two-sided file support.
- Authority hierarchy, master source-of-truth hierarchy, and prednisone-specific hierarchy are covered.
- Temporal boundary is preserved: no world-level file after 05/23/2026 18:00.

Accepted watch items:

- Future File Inventory v1 table must use AutoQC v6.3 8-column structure.
- Source/Tool separation must be preserved.
- Fact-to-file traceability must be enforced.
- Essential/supplementary ratio should be checked during table construction.
- Trap #3 and Trap #5 must be instantiated as distinct source patterns.
- Objective trend and MAR values remain future synthetic-file construction.
- Social Work and remote procedural provenance remain final-table judgment calls.
- Transcript packaging remains future submission-layer work.

Phase 3 File Inventory Architecture:

- Status: COMPLETE.

Next eligible phase:

- File Inventory v1 Table Construction, pending explicit Alexander authorization.

Boundary:

- This does not authorize final Section 3 file rows, filenames, file IDs, synthetic files, clinical notes, labs, vitals, medication lists, discharge summaries, task prompts, expected outputs, goldens, grader guidance, AutoQC responses, DOCX artifacts, or submission materials.

## File Inventory v1

Status: LOCKED.

Artifact: `worlds/korvin-merrow/file-inventory/locked/file-inventory-v1.md`

Ratification: `worlds/korvin-merrow/file-inventory/ratifications/file-inventory-v1-ratification.md`

Review outcome:

- Claude Code Review: YES / LOCK READY / GO.
- Windsurf Claude Review: YES / LOCK READY / GO.
- No true defects identified.
- No blockers identified.
- World Spec fidelity verified.
- File Inventory Architecture fidelity verified.
- All 33 planned files validated.
- ID integrity, count integrity, temporal integrity, workflow coverage, trap coverage, friction coverage, source-of-truth coverage, and AutoQC v6.3 structure verified.
- Source vs Tool separation preserved.
- Trap #3 vs Trap #5 distinction preserved.
- No answer-file risk identified.
- No post-world leakage identified.

Locked counts:

- World-Level files: 22.
- Task-Level files: 7.
- Supplementary files: 4.
- Total planned files: 33.

Accepted carry-forward items:

- Per-file Tool / Origin values remain future synthetic-file construction work.
- Two-track filename convention remains future synthetic-file construction work.
- FI-W12 trend representation remains future synthetic-file construction work.
- FI-W13 MAR representation remains future synthetic-file construction work.
- Trap remediation paths remain future grader-guidance work.
- Transcript packaging remains future submission-layer work.

File Inventory Planning:

- Status: COMPLETE.

Next eligible phase:

- Synthetic World-Level File Construction, pending explicit Alexander authorization.

Boundary:

- This does not authorize synthetic files, file contents, clinical notes, progress notes, discharge summaries, labs, vitals, medication lists, consultant recommendations, task prompts, expected outputs, goldens, grader guidance, AutoQC responses, DOCX artifacts, submission materials, or RL Studio activity.

## Synthetic World-Level File Construction Plan v1

Status: LOCKED.

Artifact: `worlds/korvin-merrow/synthetic-files/locked/synthetic-world-file-construction-plan-v1.md`

Ratification: `worlds/korvin-merrow/synthetic-files/ratifications/synthetic-world-file-construction-plan-v1-ratification.md`

Review outcome:

- Claude Code Review: YES / LOCK READY / GO.
- Windsurf Claude Review: YES / LOCK READY / GO.
- No true defects identified.
- No blockers identified.
- All 22 FI-W world-level rows accounted for.
- No missing IDs, duplicated IDs, or invented IDs.
- Dependency ordering and batch sequencing verified.
- FI-W22 construction-last strategy endorsed.
- Trap preservation, friction preservation, source-of-truth preservation, temporal preservation, construction governance, anti-answer-file doctrine, and closed-world discipline verified.
- Batch 1 construction readiness verified.

Accepted carry-forward items:

- Batch 3 and Batch 4 may remain sequential or run in parallel after Batch 2.
- Cross-file consistency checkpoint remains future construction governance.
- Per-file Tool / Origin assignment remains future file-construction work.
- FI-W12 trend representation remains future construction work.
- FI-W13 MAR representation remains future construction work.
- Synthetic file content remains future construction work.

Synthetic File Construction Governance:

- Status: COMPLETE.

Next eligible phase:

- Batch 1 Synthetic World-Level File Construction, pending explicit Alexander authorization.

Boundary:

- This does not authorize synthetic files, filenames, chart notes, admission notes, consultant notes, nursing notes, therapy notes, discharge summaries, labs, vitals, medication lists, medication schedules, task prompts, expected outputs, goldens, grader guidance, AutoQC responses, submission artifacts, DOCX artifacts, or RL Studio activity.

## Batch 1 Synthetic World-Level File Construction

Status: LOCKED.

Locked folder: `worlds/korvin-merrow/synthetic-files/locked/batch-1/`

Validation review: `worlds/korvin-merrow/synthetic-files/locked/batch-1/batch-1-validation-review.md`

Ratification: `worlds/korvin-merrow/synthetic-files/ratifications/batch-1-ratification.md`

Authorized files constructed:

- FI-W01: ED triage / initial intake documentation.
- FI-W02: ED provider assessment.
- FI-W03: Admission history and physical.
- FI-W04: Initial medication reconciliation note.
- FI-W05: Pharmacy / refill-history report.
- FI-W06: Outpatient rheumatology prednisone provenance.
- FI-W07: Primary care outpatient baseline summary.

Construction governance:

- Used locked File Inventory v1 row purposes.
- Preserved closed-world discipline.
- Preserved locked timeline and HD1 / pre-admission provenance boundaries.
- Preserved locked diagnoses, medication architecture, provider roster, source-of-truth hierarchies, and active frictions.
- Preserved Trap #1 as a reconstructable prednisone source hierarchy across rheumatology, med rec, pharmacy history, family report, and patient recollection.
- Preserved Trap #2 substrate through HF/AKI medication complexity without creating final medication recommendations.
- No answer file created.

Validation result:

- FI-W01 through FI-W07 exist.
- All files map to locked inventory rows.
- No unauthorized FI-W IDs created.
- No temporal leakage identified.
- Prednisone hierarchy preserved.
- Source-of-truth hierarchy preserved.
- Frictions preserved.

Review outcome:

- Claude Code Review: YES / LOCK READY / GO.
- Windsurf Claude Review: YES / LOCK READY / GO.
- No true defects identified.
- No blockers identified.
- All 7 Batch 1 files validated against locked File Inventory rows.
- Cross-file identity, provider, medication, comorbidity, surgical-history, and baseline-anchor consistency verified.
- Insulin lispro exclusion preserved.
- Prednisone hierarchy preserved.
- Source-of-truth hierarchies preserved.
- Temporal integrity preserved.
- No post-world leakage.
- No answer-file drift.
- Trap and friction preservation verified.

Accepted carry-forward items:

- FI-W06 availability remains governed by HD4 timing during future construction.
- Batch 2 must preserve prednisone uncertainty.
- Batch 2 must preserve infection-vs-mixed-physiology uncertainty.
- Batch 2 must preserve medication-restart uncertainty.
- Batch 2 must preserve baseline-vs-admission-value separation.
- Batch 2 must preserve all hierarchy ordering.

Final status:

- Batch 1 Synthetic World-Level File Construction: LOCKED.
- FI-W01 through FI-W07: LOCKED.
- Batch 1 Construction: COMPLETE.

Next eligible phase:

- Batch 2 Synthetic World-Level File Construction.

Boundary:

- FI-W14 or later, task prompts, expected outputs, goldens, grader guidance, AutoQC responses, submission artifacts, DOCX artifacts, and RL Studio activity remain blocked until explicitly authorized.

## Batch 2 Synthetic World-Level File Construction

Status: LOCKED.

Locked folder: `worlds/korvin-merrow/synthetic-files/locked/batch-2/`

Validation review: `worlds/korvin-merrow/synthetic-files/locked/batch-2/batch-2-validation-review.md`

Ratification: `worlds/korvin-merrow/synthetic-files/ratifications/batch-2-ratification.md`

Authorized files constructed:

- FI-W08: HD1-HD2 hospitalist progress documentation.
- FI-W09: HD3 hospitalist progress documentation.
- FI-W10: HD4 hospitalist progress documentation.
- FI-W11: HD5-HD6 hospitalist discharge-planning progress documentation.
- FI-W12: objective renal / infection / hemodynamic trend summary source.
- FI-W13: medication administration / inpatient medication action source.

Construction governance:

- Used locked File Inventory v1 row purposes.
- Preserved closed-world discipline through 05/23/2026 at 18:00.
- Preserved locked diagnoses, medication architecture, provider roster, source-of-truth hierarchies, and active frictions.
- Preserved FI-W06 HD4 availability timing.
- Preserved insulin lispro as inpatient-only medication action logic, not baseline medication architecture.
- Preserved baseline-versus-admission-value separation.
- Preserved Trap #1, strengthened Trap #2 substrate, and preserved Trap #3 versus Trap #5 distinction.
- No answer file created.

Validation result:

- FI-W08 through FI-W13 exist.
- All files map to locked inventory rows.
- No unauthorized FI-W IDs created.
- No temporal leakage identified.
- No discharge outcome, +7 information, or +30 information created.
- Source-of-truth hierarchy preserved.
- Frictions preserved.
- Batch 1 consistency preserved.

Ratification review outcome:

- Claude Code Review: YES / LOCK READY / GO.
- Windsurf Claude Review: YES / LOCK READY / GO.
- No true defects identified.
- No blockers identified.
- Hospital-course spine verified.
- FI-W12 objective trend values verified as clinically coherent.
- FI-W13 MAR/action source verified as non-final and non-discharge-facing.
- FI-W06 HD4 availability constraint preserved.
- Baseline-versus-admission-value distinction preserved.
- Insulin lispro remains inpatient-only.
- Baseline medication count remains 20.
- Trap #1 preserved.
- Trap #2 strengthened without over-resolution.
- Trap #3 and Trap #5 distinction preserved.
- Trap #4 preserved without sepsis reversal.
- All three frictions remain two-sided.
- No answer-file drift identified.
- No post-world leakage identified.

Accepted carry-forward items:

- Batch 3 consultants must respond to the Batch 1-2 clinical spine.
- Nephrology and Cardiology must remain defensible and time-sensitive.
- Endocrinology must remain interpretive, not a hidden single-diagnosis reveal.
- Prednisone hierarchy must preserve rheumatology as highest outpatient taper authority.
- FI-W12 values must not be overused by later files as if they settle medication restart or disposition.
- FI-W13 actions must not become a final discharge medication plan.

Final status:

- Batch 2 Synthetic World-Level File Construction: LOCKED.
- FI-W08 through FI-W13: LOCKED.
- Batch 2 Construction: COMPLETE.

Next eligible phase:

- Batch 3 Synthetic World-Level File Construction.

Boundary:

- Historical Batch 2 lock boundary: FI-W14 through FI-W22, task prompts, expected outputs, goldens, grader guidance, AutoQC responses, submission artifacts, DOCX artifacts, and RL Studio activity were blocked at that time until explicitly authorized.
- Historical note: this was the Batch 2 lock boundary at the time of that ratification. It is superseded for FI-W14 through FI-W16 by the Batch 3 ratification, for FI-W17 through FI-W21 by the Batch 4 construction record below, and for FI-W22 by the Batch 5 candidate construction record below.

## Task-Design Physician-Perspective Guidance

Status: FUTURE TASK-LAYER RULE.

Source: Medicine Team Lead Slack clarification.

Classification:

- Not a source-of-truth hierarchy rule.
- Not a Governance Package v1 revision.
- Not a reason to redesign the world or reopen locked clinical architecture.

Distinction:

- Source-of-truth hierarchy answers: "When sources disagree, which evidence source is authoritative?"
- Task-design guidance answers: "Who is the final deliverable written by or for?"

Future task-design rule:

- All future task prompts and deliverables must be framed from the physician perspective or physician voice.
- Supporting sources may come from pharmacy, nursing, PT/OT, case management, social work, family, or healthcare administration.
- The final deliverable must remain physician-authored, physician-reviewed, physician-supervised, or physician-communicated.

Current workflow compatibility:

- Discharge Medication Reconciliation: compatible.
- Hospital Discharge Summary Generation: compatible.
- Discharge Planning Documentation: compatible.
- Interdisciplinary Care Plan Development and Documentation: compatible.

Carry-forward instruction:

- Apply this rule later during authorized task design, task prompts, expected outputs, goldens, and grader guidance.
- Do not modify source-of-truth hierarchies, Governance Package v1, locked clinical architecture, or locked synthetic files because of this guidance.

## Batch 3 Synthetic World-Level File Construction Ratification

Status: LOCKED.

Files locked:

- FI-W14 Nephrology Consultation.
- FI-W15 Cardiology Consultation.
- FI-W16 Endocrinology Consultation.

Canonical locked path:

- `worlds/korvin-merrow/synthetic-files/locked/batch-3/`

Ratification record:

- `worlds/korvin-merrow/synthetic-files/ratifications/batch-3-ratification.md`

Validation review:

- `worlds/korvin-merrow/synthetic-files/locked/batch-3/batch-3-validation-review.md`

Review outcome:

- Claude Code Review: YES / LOCK READY / GO.
- Windsurf Claude Review: YES / LOCK READY / GO.
- No true defects identified.
- No blockers identified.

Accepted findings:

- FI-W14 through FI-W16 validate against locked File Inventory rows.
- Nephrology consultation is clinically defensible.
- Cardiology consultation is clinically defensible.
- Endocrinology consultation is clinically defensible.
- Cardiology vs Nephrology remains a timing and sequencing friction.
- Neither Cardiology nor Nephrology is obviously correct or careless.
- Neither consultant becomes the final medication-restart authority.
- Endocrinology remains interpretive.
- Adrenal insufficiency is not proven.
- Steroid risk remains meaningful but not dominant.
- Prednisone hierarchy is preserved with Rheumatology as highest outpatient taper authority.
- Consultant notes remain interpretation sources, not source-of-truth overrides.
- Hospitalist-synthesizes-not-defers governance is preserved.
- FI-W12 values are cited consistently.
- FI-W13 MAR/action source is not converted into a final medication plan.
- Insulin lispro remains inpatient-only.
- No answer-file drift identified.
- No post-world leakage identified.
- Batch 1 and Batch 2 consistency preserved.

Accepted carry-forward items:

- Batch 4 must carry buried functional and cognitive evidence.
- Batch 4 must preserve Trap #3 as buried-but-discoverable evidence.
- Batch 4 must preserve the Trap #3 vs Trap #5 distinction.
- FI-W20 family communication must not make discharge obviously unsafe by itself.
- FI-W22 later must remain visible-but-incomplete and must not duplicate or resolve all consultant caveats.
- Later files must not let Endocrinology replace Rheumatology as prednisone-history source of truth.
- Later files must not let either consultant become the final medication authority.

Final status:

- Batch 3 Synthetic World-Level File Construction: LOCKED.
- FI-W14 through FI-W16: LOCKED.
- Batch 3 Construction: COMPLETE.

Next eligible phase:

- Batch 4 Synthetic World-Level File Construction.

Boundary:

- Historical Batch 3 lock boundary: FI-W17 through FI-W22, task prompts, expected outputs, goldens, grader guidance, AutoQC responses, submission artifacts, DOCX artifacts, and RL Studio activity were blocked at that time until explicitly authorized.
- Historical note: this was the Batch 3 lock boundary at the time of that ratification. It is superseded for FI-W17 through FI-W21 by the Batch 4 construction record below and for FI-W22 by the Batch 5 candidate construction record below.

## Batch 4 Synthetic World-Level File Construction Record

Status: LOCKED.

Files locked:

- FI-W17 Nursing Documentation.
- FI-W18 Physical Therapy Documentation.
- FI-W19 Occupational Therapy Documentation.
- FI-W20 Family Communication Documentation.
- FI-W21 Case Management / Social Work Documentation.

Locked path:

- `worlds/korvin-merrow/synthetic-files/locked/batch-4/`

Validation review:

- `worlds/korvin-merrow/synthetic-files/locked/batch-4/batch-4-validation-review.md`

Ratification:

- `worlds/korvin-merrow/synthetic-files/ratifications/batch-4-ratification.md`

Construction findings:

- FI-W17 through FI-W21 were created within the authorized Batch 4 scope.
- Trap #3 is carried as buried functional/cognitive evidence distributed across nursing, PT, OT, family, and case management/social work.
- Trap #3 vs Trap #5 remains distinct; Batch 4 does not create FI-W22 or a visible discharge-facing artifact.
- Family vs Primary Team friction remains balanced and two-sided.
- Family concerns are clinically meaningful but not independently dispositive.
- Primary-team medical-improvement reasoning remains defensible.
- Medication-restart uncertainty remains active.
- Prednisone uncertainty and the prednisone source hierarchy remain active.
- Insulin lispro remains inpatient-only.
- Batch 1, Batch 2, and Batch 3 consistency is preserved.

Accepted carry-forward items:

- Batch 4 is locked and complete.
- FI-W22 later must remain visible-but-incomplete.
- FI-W22 must not duplicate or resolve all Batch 4 functional/cognitive evidence.
- FI-W22 must not resolve final disposition, final medication restart, final prednisone taper, or all consultant caveats.
- Later files must preserve family concerns as meaningful but not independently dispositive.

Final status:

- Batch 4 Synthetic World-Level File Construction: LOCKED.
- FI-W17 through FI-W21: LOCKED.
- Batch 4 Construction: COMPLETE.

Next eligible phase:

- Batch 5 Candidate Review and ratification decision.

## FI-W20 Inventory Row Reconciliation Record

Status:

- RECORDED.

Context:

- Batch 4 governance reconciliation resolved the FI-W20 supported-tags question by expanding the locked File Inventory v1 FI-W20 row rather than reducing the constructed FI-W20 candidate file.

Resolution:

- Canonical resolution: expand the locked FI-W20 row to record secondary/collateral Trap #1 and Endocrinology vs Primary Team support through lower-authority family report.
- Reconciliation record: `worlds/korvin-merrow/file-inventory/reviews/fi-w20-inventory-row-reconciliation.md`.

Preserved boundaries:

- FI-W20 content unchanged.
- Batch 4 content unchanged.
- Batch 1 through Batch 3 content unchanged.
- Source-of-truth hierarchy unchanged.
- Prednisone hierarchy unchanged: rheumatology attending recommendation remains highest outpatient prednisone authority, followed by verified medication reconciliation, pharmacy/refill history, family report, and patient recollection.
- Batch 4 is locked by the Batch 4 ratification record.

Next eligible phase:

- Batch 5 Synthetic World-Level File Construction.

Boundary:

- Batch 5 lock, task prompts, expected outputs, goldens, grader guidance, AutoQC responses, submission artifacts, DOCX artifacts, and RL Studio activity remain blocked until explicitly authorized.

## Batch 4 Synthetic World-Level File Construction Ratification Record

Status:

- LOCKED.

Files locked:

- FI-W17 through FI-W21.

Ratification:

- `worlds/korvin-merrow/synthetic-files/ratifications/batch-4-ratification.md`.

Locked folder:

- `worlds/korvin-merrow/synthetic-files/locked/batch-4/`.

Validation review:

- `worlds/korvin-merrow/synthetic-files/locked/batch-4/batch-4-validation-review.md`.

Review outcome:

- Claude Code Review: YES / LOCK READY / GO.
- Windsurf Claude Review: YES / LOCK READY / GO.
- FI-W20 governance reconciliation completed.
- No remaining OPEN items.
- No remaining BLOCKERs.

Accepted carry-forward items:

- FI-W22 must remain visible-but-incomplete.
- FI-W22 must not duplicate the distributed Batch 4 substrate.
- FI-W22 must not resolve final disposition, medication restart timing, or prednisone history.
- FI-W22 must not collapse Trap #3 into Trap #5.
- Family concerns must remain meaningful but not dispositive.
- Consultant caveats must remain partially absent from FI-W22.
- FI-W22 must preserve the distinction between visible evidence and complete evidence.

Status record:

- Batch 4 Synthetic World-Level File Construction: LOCKED.
- FI-W17 through FI-W21: LOCKED.
- Batch 4 Construction: COMPLETE.
- FI-W20 reconciliation: COMPLETE.

Next eligible phase:

- Batch 5 Candidate Review and ratification decision.

Boundary:

- Batch 5 lock, task prompts, expected outputs, goldens, grader guidance, AutoQC responses, submission artifacts, DOCX artifacts, and RL Studio activity remain blocked until explicitly authorized.

## Batch 5 Synthetic World-Level File Construction Record

Status:

- CANDIDATE REVIEW.

Files constructed:

- FI-W22 Discharge-Facing Plan Snapshot Before World Close.

Candidate path:

- `worlds/korvin-merrow/synthetic-files/candidate-review/batch-5/`

Validation review:

- `worlds/korvin-merrow/synthetic-files/candidate-review/batch-5/batch-5-validation-review.md`

Construction findings:

- FI-W22 was created within the authorized Batch 5 scope.
- FI-W22 implements Trap #5 as a visible, reassuring, but incomplete discharge-facing artifact.
- FI-W22 preserves the Trap #3 vs Trap #5 distinction by not duplicating the distributed Batch 4 functional/cognitive substrate.
- FI-W22 preserves Cardiology vs Nephrology as a timing and sequencing friction without choosing the final medication-restart answer.
- FI-W22 preserves Endocrinology vs Primary Team as an interpretive steroid-risk friction without proving adrenal insufficiency.
- FI-W22 preserves Family vs Primary Team as a balanced discharge-readiness friction.
- FI-W22 preserves the prednisone source hierarchy with rheumatology as highest outpatient taper authority.
- FI-W22 contains no discharge outcome, post-world follow-up, final medication list, final prednisone taper, task prompt, golden, grader guidance, AutoQC response, DOCX artifact, or submission material.

Carry-forward items:

- Candidate review must test whether FI-W22 is too complete or too explicitly caveated.
- FI-W22 must remain useful, visible, and reassuring but insufficient if trusted alone.
- FI-W22 must not resolve final disposition, medication restart timing, prednisone history, consultant disagreement, family concern, functional support level, or service sufficiency.
- Future task files must not turn FI-W22 into the source-of-truth answer.
- Future task prompts, expected outputs, goldens, and grader guidance remain blocked until explicitly authorized and must preserve physician-perspective task-design guidance.

Final status:

- Batch 5 Synthetic World-Level File Construction: CANDIDATE REVIEW.
- FI-W22: CANDIDATE.
- Batch 5 Construction: COMPLETE pending review and ratification decision.

Next eligible phase:

- Batch 5 Candidate Review and ratification decision.

Boundary:

- Batch 5 lock, task prompts, expected outputs, goldens, grader guidance, AutoQC responses, submission artifacts, DOCX artifacts, and RL Studio activity remain blocked until explicitly authorized.
